Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

92
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
92
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

89
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
89
  1. Home
  2. Research Domains
  3. Biomedical And Clinical Sciences
  4. Oncology And Carcinogenesis
  5. Predictive And Prognostic Markers
  6. Primary Sclerosing Cholangitis And Pancreatic Cancer: A Retrospective Cohort Study Of United States Veterans.

Primary sclerosing cholangitis and pancreatic cancer: A retrospective cohort study of United States veterans.

Anita Nguyen1,2, Babak Torabi Sagvand1,3, Madeline Alizadeh1,4

  • 1Department of Veterans Affairs, Veterans Affairs (VA) Maryland Health Care System, Baltimore, MD, United States.

Frontiers in Gastroenterology (Lausanne, Switzerland)
|February 13, 2024

Related Experiment Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

268
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

10.6K

View abstract on PubMed

Summary
This summary is machine-generated.

Veterans with primary sclerosing cholangitis (PSC) have a higher risk of pancreatic cancer, especially those without inflammatory bowel disease (IBD). Further research is needed to explore screening benefits for PSC patients.

Area of Science:

  • Gastroenterology
  • Oncology
  • Epidemiology

Background:

  • Primary sclerosing cholangitis (PSC) is linked to hepatobiliary and colorectal cancers.
  • The association between PSC and pancreatic cancer risk is uncertain, with conflicting evidence from European studies.
  • Previous studies often did not adequately consider the presence or absence of concomitant inflammatory bowel disease (IBD).

Purpose of the Study:

  • To investigate the prevalence of pancreatic cancer in United States veterans diagnosed with PSC.
  • To compare pancreatic cancer prevalence in PSC patients with and without concurrent IBD.
  • To assess pancreatic cancer risk in PSC patients relative to IBD patients and the general veteran population.

Main Methods:

  • Retrospective study utilizing the Veterans Affairs (VA) Corporate Data Warehouse.
Keywords:
IBDPSCinflammatory bowel diseasepancreatic adenocarcinoma

Related Experiment Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

268
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

10.6K
  • Identification of patients using International Classification of Diseases, Tenth Revision (ICD-10) codes for PSC, IBD, and pancreatic cancer.
  • Logistic regression analysis to control for confounding factors including age, gender, chronic pancreatitis, diabetes mellitus, and tobacco/alcohol use.
  • Main Results:

    • A total of 946 PSC patients were identified among over 9 million veterans; 51.4% had concurrent IBD.
    • Adjusted analysis revealed a significantly higher prevalence of pancreatic cancer in PSC patients (2.4%) compared to those with IBD only (0.5%) and the general veteran population (0.2%).
    • The prevalence of pancreatic cancer was notably higher in PSC patients without concomitant IBD.

    Conclusions:

    • Veterans with PSC exhibit a high prevalence of pancreatic cancer, particularly those without IBD, when compared to the general veteran population.
    • These findings underscore the need for further investigation into pancreatic cancer screening for PSC patients.
    • Multicenter prospective studies are recommended to evaluate the benefits of early pancreatic cancer detection in individuals with PSC.
    pancreatic cancer
    primary sclerosing cholangitis
    veteran